<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>18 patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) but without an HLA-identical sibling were treated by antilymphocyte globulin (ALG) followed by infusion of marrow cells from a semi-compatible family donor </plain></SENT>
<SENT sid="1" pm="."><plain>13 of these received low dose <z:chebi fb="5" ids="50113">androgens</z:chebi> after ALG: 11 (85%) achieved stable remission without transfusion requirement </plain></SENT>
<SENT sid="2" pm="."><plain>One patient relapsed after 4 months, one patient with only partial remission died from <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>None of the 4 patients who did not receive <z:chebi fb="5" ids="50113">androgens</z:chebi> after ALG achieved remission </plain></SENT>
<SENT sid="4" pm="."><plain>ALG, marrow and low-dose <z:chebi fb="5" ids="50113">androgens</z:chebi> represent a promising therapy for SAA and can be favorably compared with allogeneic bone marrow transplantation </plain></SENT>
</text></document>